Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

CD40-CD40L interactions in atherosclerosis.

Esther Lutgens¹, Mat J A P Daemen

¹Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.

Trends in Cardiovascular Medicine

|February 14, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification.

Biomolecules·2026

Same author

Arteriovenous fistula creation results in cardiac dysfunction and remodeling in a uremic pig model.

American journal of physiology. Renal physiology·2026

Same author

ADAMTS13 and von Willebrand Factor in relation to vascular cognitive impairment and cerebral small vessel disease: the heart-brain connection study.

Journal of thrombosis and haemostasis : JTH·2026

Same author

Traditional Risk Factors Provide Limited Insight Into Long-Term Cardiovascular Risk After Carotid Endarterectomy.

Mayo Clinic proceedings·2026

Same author

Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities.

European heart journal·2026

Same author

Functional and Transcriptional Senescence Profiles of CD8+ T Cells Associate With the Presence of Carotid Plaques in People Living With HIV.

The Journal of infectious diseases·2026

Inhibiting CD40 ligand (CD40L) promotes stable atherosclerotic plaques by reducing inflammatory cells. This suggests CD40L inhibition could prevent plaque rupture and its complications.

Area of Science:

Cardiovascular Biology
Immunology
Atherosclerosis Research

Background:

CD40-CD40L interactions are increasingly implicated in atherosclerosis.
Previous studies showed CD40L deficiency in ApoE(-/-) mice yields stable plaques.

Purpose of the Study:

To investigate the therapeutic potential of CD40L inhibition in preventing atherosclerotic plaque destabilization.
To analyze the cellular composition of plaques following CD40L inhibition.

Main Methods:

Utilized ApoE(-/-) mouse models of atherosclerosis.
Administered pharmacological CD40L inhibition.
Analyzed plaque stability, cellular content (smooth muscle cells, collagen, macrophages, T-lymphocytes), and CD40/CD40L expression in human lesions.

Related Experiment Videos

Main Results:

CD40L deficiency and pharmacological inhibition led to stable atherosclerotic plaques rich in smooth muscle cells and collagen.
These stable plaques had significantly fewer macrophages and T-lymphocytes.
CD40 and CD40L proteins were found in human atherosclerotic lesions, with higher expression in advanced, rupture-prone plaques.

Conclusions:

CD40L inhibition promotes a stable atherosclerotic plaque phenotype.
Targeting CD40L may represent a novel therapeutic strategy to prevent plaque rupture and associated cardiovascular events.